Public Policy

Just a few days after winning the election, the incoming Trump Administration began to identify key health policy proposals. Some of these priorities include addressing mental health issues and tackling the opioid overdose crisis, accelerating translational research, and improving rural health. The National Institutes of Health (NIH) remains under scrutiny, with ongoing discussions surrounding its... Read More

For Immediate Release: August 5, 2024, 11:30 a.m. U.S. Eastern Time Media Contact: Kara Flynn, (202) 257-8424, press@ashg.org American Society of Human Genetics (ASHG) President Bruce D. Gelb, M.D., released the following statement in response to the U.S. Senate Appropriations Committee’s approval by a 25-3 vote of the fiscal year (FY) 2025 bill for the... Read More

In May 2024, ASHG hosted a fourth year of virtual advocacy meetings with policymakers on Capitol Hill. Over the course of a week, participants in the  2024 cohort of the Advocacy Certificate for Human Genetics and Genomics Trainees (ACGT) program joined members of past  ACGT  cohorts and members of the  Government and Public Advocacy Committee (GPAC)  in meetings with 15 congressional... Read More

For the benefits of human genetics and genomics research to be realized by all people, research studies must reflect humanity’s diversity. This will take a concerted effort by the research community and greater engagement with individuals and communities underrepresented in research. Policymakers play a pivotal role in shaping the landscape of genetic research, healthcare, and... Read More

ASHG recently spoke with Julie Gerberding, MD, MPH, President and CEO of the Foundation for the National Institutes of Health (FNIH), on how this organization leverages expertise across a breadth of scientific industries to address complex health challenges and accelerate research, particularly in human genetics and genomics.  The FNIH is an independent, not-for-profit 501(c)(3) charitable... Read More